Cargando…
Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male
Primary hyperparathyroidism is a very rare complication following radioactive iodine therapy. There is typically a latency period of more than a decade following radiation exposure and, therefore, it is observed almost exclusively in adults. Consequently, pediatricians are not aware of the associati...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926218/ https://www.ncbi.nlm.nih.gov/pubmed/24592349 http://dx.doi.org/10.1155/2014/163848 |
_version_ | 1782303937576042496 |
---|---|
author | Gomez, Danielle L. Shulman, Dorothy I. |
author_facet | Gomez, Danielle L. Shulman, Dorothy I. |
author_sort | Gomez, Danielle L. |
collection | PubMed |
description | Primary hyperparathyroidism is a very rare complication following radioactive iodine therapy. There is typically a latency period of more than a decade following radiation exposure and, therefore, it is observed almost exclusively in adults. Consequently, pediatricians are not aware of the association. We present a case of primary hyperparathyroidism due to a solitary parathyroid adenoma occurring in an adolescent male two years following radioactive iodine treatment for papillary thyroid carcinoma. Periodic screening of serum calcium following ablative doses of radioactive iodine for thyroid cancer may be justified even in adolescents. |
format | Online Article Text |
id | pubmed-3926218 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-39262182014-03-03 Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male Gomez, Danielle L. Shulman, Dorothy I. Case Rep Pediatr Case Report Primary hyperparathyroidism is a very rare complication following radioactive iodine therapy. There is typically a latency period of more than a decade following radiation exposure and, therefore, it is observed almost exclusively in adults. Consequently, pediatricians are not aware of the association. We present a case of primary hyperparathyroidism due to a solitary parathyroid adenoma occurring in an adolescent male two years following radioactive iodine treatment for papillary thyroid carcinoma. Periodic screening of serum calcium following ablative doses of radioactive iodine for thyroid cancer may be justified even in adolescents. Hindawi Publishing Corporation 2014 2014-01-30 /pmc/articles/PMC3926218/ /pubmed/24592349 http://dx.doi.org/10.1155/2014/163848 Text en Copyright © 2014 D. L. Gomez and D. I. Shulman. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Gomez, Danielle L. Shulman, Dorothy I. Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title | Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_full | Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_fullStr | Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_full_unstemmed | Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_short | Hyperparathyroidism Two Years after Radioactive Iodine Therapy in an Adolescent Male |
title_sort | hyperparathyroidism two years after radioactive iodine therapy in an adolescent male |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3926218/ https://www.ncbi.nlm.nih.gov/pubmed/24592349 http://dx.doi.org/10.1155/2014/163848 |
work_keys_str_mv | AT gomezdaniellel hyperparathyroidismtwoyearsafterradioactiveiodinetherapyinanadolescentmale AT shulmandorothyi hyperparathyroidismtwoyearsafterradioactiveiodinetherapyinanadolescentmale |